## RJF: Raymond James Financial, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.22 indicates fundamental undervaluation. Quality metrics strong (ROE 18%).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($157.21)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Raymond James Investment Management names new president**
- Source: Pensions & Investments | 20251215T160831 | Neutral | Relevance: 100%
- Jeff Ringdahl has been appointed as the new president of Raymond James Investment Management. The announcement was made on December 15, 2025, at 11:22 AM EST. This move is part of the "People on the Move" section by Pensions & Investments.

**2. Raymond James IM names Jeff Ringdahl as new president**
- Source: International Adviser | 20251215T150444 | Bullish | Relevance: 100%
- Raymond James Investment Management (IM) has appointed Jeff Ringdahl as its new president, effective January 5th. Ringdahl will oversee the growth strategy and direction of the business, which manages around $118.5 billion in assets. He brings over 25 years of experience, including previous roles as president and COO at Summit Trail Advisors and CEO, president, and COO at American Beacon Partners.

**3. Stance Capital LLC Purchases New Holdings in Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251214T124548 | Somewhat-Bullish | Relevance: 100%
- Stance Capital LLC significantly increased its investment in Raymond James Financial, Inc. by acquiring 16,355 shares valued at approximately $2.5 million during the second quarter, making it their 17th largest holding. Other institutional investors like Princeton Global Asset Management LLC and TD Private Client Wealth LLC also boosted their stakes. The article details analyst ratings, price targets, and the financial performance of Raymond James Financial, including its recent dividend increase.

**4. Raymond James Financial (RJF) Gets a Hold from UBS**
- Source: The Globe and Mail | 20251212T122056 | Somewhat-Bullish | Relevance: 100%
- UBS initiated coverage on Raymond James Financial (RJF) with a Hold rating and a $176.00 price target. This aligns with the overall analyst consensus of Hold, with a slightly higher target of $184.13. The company recently reported strong quarterly revenues of $4.35 billion, up from $3.95 billion last year.

**5. Qube Research & Technologies Ltd Has $79.89 Million Stock Holdings in Raymond James Financial, Inc. $RJF**
- Source: MarketBeat | 20251212T120849 | Somewhat-Bullish | Relevance: 100%
- Qube Research & Technologies Ltd reduced its stake in Raymond James Financial, Inc. by 44.3% in Q2, but still holds 520,875 shares valued at approximately $79.89 million. Raymond James exceeded quarterly earnings estimates with an EPS of $3.11 and revenue of $3.73 billion, while also increasing its quarterly dividend to $0.54 per share. Analysts currently have a consensus "Hold" rating on the stock with a price target of $180.45.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | B of A Securiti | $196 | $194 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.00M) |
| Sells | 17 ($0.08M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 11.1% (-1.4%)
- Blackrock Inc.: 7.4% (-2.9%)
- JPMORGAN CHASE & CO: 5.9% (+108.2%)
- Primecap Management : 4.9% (-3.7%)
- Wellington Managemen: 4.6% (-5.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +1.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.22 suggests fair value with growth premium. Quality metrics strong (margin 15%). Institutional flow bullish (1 buying vs 9 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.7B |
| Beta | 1.01 |
| 52W Range | $117.57 - $177.66 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.22 |
| Forward P/E | 12.2 |
| Current P/E | 13.6 |
| YoY Growth | 11.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.7% to 3.0% (+1.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.0pp (needs >4.0% for momentum thesis). MRS_5 at 0.8% confirms short-term momentum alignment. AM_20 at 3.3% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.13), confirming momentum. RSI neutral at 57. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.95% (CS: 60) | Neutral |
| RSI_14 | 57.2 | Neutral |
| MACD Histogram | 1.13 | Bullish |
| vs SMA20 | 1.033x | Above |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 1.057x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $163.85
- **Stop Loss:** $157.21 (4.1% risk)
- **Target:** $177.13 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 180
- **Position Value:** $29,493.00
- **Portfolio %:** 29.49%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-01-28 (Est: $2.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.11 | +10.0% |
| 2025Q2 | $2.36 | $2.18 | -7.5% |
| 2025Q1 | $2.44 | $2.42 | -0.7% |
| 2024Q4 | $2.69 | $2.93 | +8.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*